These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38443629)

  • 1. Intravitreal Delivery of PEGylated-ECO Plasmid DNA Nanoparticles for Gene Therapy of Stargardt Disease.
    Sun D; Sun W; Gao SQ; Lehrer J; Wang H; Hall R; Lu ZR
    Pharm Res; 2024 Apr; 41(4):807-817. PubMed ID: 38443629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.
    Sun D; Schur RM; Sears AE; Gao SQ; Vaidya A; Sun W; Maeda A; Kern T; Palczewski K; Lu ZR
    Mol Ther; 2020 Jan; 28(1):293-303. PubMed ID: 31611143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective gene therapy of Stargardt disease with PEG-ECO/
    Sun D; Sun W; Gao SQ; Lehrer J; Naderi A; Wei C; Lee S; Schilb AL; Scheidt J; Hall RC; Traboulsi EI; Palczewski K; Lu ZR
    Mol Ther Nucleic Acids; 2022 Sep; 29():823-835. PubMed ID: 36159595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model.
    Sun D; Sun W; Gao SQ; Wei C; Naderi A; Schilb AL; Scheidt J; Lee S; Kern TS; Palczewski K; Lu ZR
    J Control Release; 2021 Feb; 330():329-340. PubMed ID: 33358976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
    Kong J; Kim SR; Binley K; Pata I; Doi K; Mannik J; Zernant-Rajang J; Kan O; Iqball S; Naylor S; Sparrow JR; Gouras P; Allikmets R
    Gene Ther; 2008 Oct; 15(19):1311-20. PubMed ID: 18463687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual
    Dyka FM; Molday LL; Chiodo VA; Molday RS; Hauswirth WW
    Hum Gene Ther; 2019 Nov; 30(11):1361-1370. PubMed ID: 31418294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.
    Parker MA; Erker LR; Audo I; Choi D; Mohand-Said S; Sestakauskas K; Benoit P; Appelqvist T; Krahmer M; Ségaut-Prévost C; Lujan BJ; Faridi A; Chegarnov EN; Steinkamp PN; Ku C; da Palma MM; Barale PO; Ayelo-Scheer S; Lauer A; Stout T; Wilson DJ; Weleber RG; Pennesi ME; Sahel JA; Yang P
    Am J Ophthalmol; 2022 Aug; 240():285-301. PubMed ID: 35248547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An AAV Dual Vector Strategy Ameliorates the Stargardt Phenotype in Adult
    McClements ME; Barnard AR; Singh MS; Charbel Issa P; Jiang Z; Radu RA; MacLaren RE
    Hum Gene Ther; 2019 May; 30(5):590-600. PubMed ID: 30381971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for Stargardt disease associated with ABCA4 gene.
    Han Z; Conley SM; Naash MI
    Adv Exp Med Biol; 2014; 801():719-24. PubMed ID: 24664763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split AAV8 Mediated ABCA4 Expression for Gene Therapy of Mouse Stargardt Disease (STGD1).
    Li R; Jing Q; She K; Wang Q; Jin X; Zhao Q; Su J; Song L; Fu J; Wu X; Xu Q; Lu F; Wei Y; Yang Y
    Hum Gene Ther; 2023 Jul; 34(13-14):616-628. PubMed ID: 37227014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.
    Han Z; Conley SM; Makkia RS; Cooper MJ; Naash MI
    J Clin Invest; 2012 Sep; 122(9):3221-6. PubMed ID: 22886305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Type-Specific Complement Profiling in the ABCA4
    Jabri Y; Biber J; Diaz-Lezama N; Grosche A; Pauly D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization of ABCA4 Missense Variants Linked to Stargardt Macular Degeneration.
    Garces FA; Scortecci JF; Molday RS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy.
    Piccardi M; Fadda A; Martelli F; Marangoni D; Magli A; Minnella AM; Bertelli M; Di Marco S; Bisti S; Falsini B
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31618812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundus autofluorescence, spectral-domain optical coherence tomography, and histology correlations in a Stargardt disease mouse model.
    Fang Y; Tschulakow A; Taubitz T; Illing B; Biesemeier A; Julien-Schraermeyer S; Radu RA; Jiang Z; Schraermeyer U
    FASEB J; 2020 Mar; 34(3):3693-3714. PubMed ID: 31989709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4
    Arunkumar R; Gorusupudi A; Li B; Blount JD; Nwagbo U; Kim HJ; Sparrow JR; Bernstein PS
    Exp Eye Res; 2021 Aug; 209():108680. PubMed ID: 34161819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of AAV Dual Vector Safety in the
    McClements ME; Barnard AR; Charbel Issa P; MacLaren RE
    Transl Vis Sci Technol; 2020 Jun; 9(7):20. PubMed ID: 32724727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
    Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
    Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease.
    Zhao J; Kim HJ; Ueda K; Zhang K; Montenegro D; Dunaief JL; Sparrow JR
    J Biol Chem; 2021; 296():100259. PubMed ID: 33837742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual AAV Vectors for Stargardt Disease.
    Trapani I
    Methods Mol Biol; 2018; 1715():153-175. PubMed ID: 29188512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.